| 1 |
CH0113817123 |
Bellevue Biotech DT CHF |
+0,34 % |
+18,48 % |
-0,11 |
| 2 |
LU2026682919 |
Candriam Equities L Biotechnology, V2 - Capitalisation |
-4,23 % |
+18,50 % |
-0,36 |
| 3 |
LU0942225912 |
Candriam Equities L Biotechnology, R - Capitalisation |
-4,45 % |
+18,48 % |
-0,37 |
| 4 |
LU0317020203 |
Candriam Equities L Biotechnology, V - Capitalisation |
-4,54 % |
+18,33 % |
-0,38 |
| 5 |
LU0133360163 |
Candriam Equities L Biotechnology, I - Capitalisation |
-4,64 % |
+18,29 % |
-0,38 |
|
|
| 24 |
LU1540961759 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD |
-4,52 % |
+16,89 % |
-0,41 |
|
|
| 73 |
DE000DWS2UA1 |
DWS ESG Biotech TFC |
-12,43 % |
+20,11 % |
-0,74 |
| 74 |
LU0959058974 |
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) CHF-H1 |
-16,50 % |
+19,62 % |
-0,96 |
| 75 |
LU1991432631 |
UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse (SEK) P-acc, SEK |
-16,05 % |
+20,74 % |
-0,89 |
| 76 |
DE000A3DCA95 |
BIT Biotech Opportunities S |
-32,28 % |
+30,22 % |
-1,14 |
| 77 |
DE000A3DCBA0 |
BIT Biotech Opportunities I-II |
-32,35 % |
+30,21 % |
-1,15 |